Sean Barbour
Scientist, MD, M.SC., FRCPC
Dr. Sean Barbour completed his internal medicine and nephrology training at the University of British Columbia (UBC) in 2010 and subsequently did a two-year Glomerulonephritis fellowship and Master of Science in Clinical Epidemiology at the University of Toronto.
Research Interests
- Glomerulonephritis
- Clinical trials
- Health outcomes
- Health services
- Clinical epidemiology
- Administrative data
- Prediction modelling
Currently, he is an Assistant Professor with the UBC Division of Nephrology, with a clinical and research focus on glomerular diseases.
He is the Medical Lead of the B.C. Provincial Renal Agency: Glomerulonephritis Network and Registry, and Chair of the B.C. Glomerulonephritis Network Steering Committee. Dr. Barbour is a Michael Smith Foundation for Health Research Scholar, and his research focus is on clinical trials, prediction modelling, health outcomes, and health services delivery in glomerulonephritis.
Additional Affiliations
- Assistant Professor, Division of Nephrology, UBC
Media Coverage
- Clinical trial paves the way for a potentially new and effective therapy for IgA nephropathy (BC Renal, May 2024)
- Study provides reassuring data on the risk of kidney disease relapse after COVID-19 vaccination (Medical Dialogues, December 2022)
- A Welcome Update to the International IgA Nephropathy Prediction Tool (Physician’s Weekly, August 2021)
- Lower income linked to certain kidney diseases (EurekAlert!, February 2020)
